Albert David Limited (NSE:ALBERTDAVD)

India flag India · Delayed Price · Currency is INR
676.45
-10.50 (-1.53%)
At close: Mar 13, 2026
Market Cap3.88B -22.4%
Revenue (ttm)3.23B -10.4%
Net Income96.12M -76.2%
EPS16.84 -76.2%
Shares Outn/a
PE Ratio40.37
Forward PEn/a
Dividend5.00 (0.74%)
Ex-Dividend DateJul 25, 2025
Volume2,924
Average Volume3,479
Open680.65
Previous Close686.95
Day's Range671.50 - 685.75
52-Week Range642.60 - 957.50
Beta-0.07
RSI42.12
Earnings DateMay 13, 2026

About Albert David

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally. It offers formulations for parenterals, oral/enterals, topical agents, aerosol, gynecology therapy, orthopedic, and vision care products. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India. [Read more]

Sector Healthcare
Founded 1938
Employees 1,805
Stock Exchange National Stock Exchange of India
Ticker Symbol ALBERTDAVD
Full Company Profile

Financial Performance

In fiscal year 2025, Albert David's revenue was 3.46 billion, a decrease of -4.61% compared to the previous year's 3.62 billion. Earnings were 172.01 million, a decrease of -77.19%.

Financial Statements